Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 3/20 | 0.81 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.81 |
| ▸ | RPS6KA5 | O75582 | 3/20 | 0.53 |
| ▸ | MAPKAPK2 | P49137 | 3/20 | 0.53 |
| ▸ | PNLIP | P16233 | 3/20 | 0.50 |
| ▸ | UGT2B7 | P16662 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MGAM | O43451 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24422153 | 0.90 | PTPN1 (1.00) | PTPN1PTPN2RPS6KA5MAPKAPK2PNLIP | |
| SCHEMBL25394431 | 0.80 | PTPN2 (0.67) | PTPN1PTPN2RPS6KA5MAPKAPK2PNLIP | |
| SCHEMBL6783507 | 0.80 | PTPN2 (0.67) | PTPN1PTPN2RPS6KA5MAPKAPK2PNLIP | |
| SCHEMBL25396294 | 0.80 | PTPN2 (0.67) | PTPN1PTPN2RPS6KA5MAPKAPK2PNLIP | |
| SCHEMBL25395895 | 0.80 | PTPN2 (0.67) | PTPN1PTPN2RPS6KA5MAPKAPK2PNLIP | |
| SCHEMBL6783502 | 0.80 | PTPN2 (0.67) | PTPN1PTPN2RPS6KA5MAPKAPK2PNLIP | |
| SCHEMBL25434992 | 0.79 | PTPN2 (0.64) | PTPN1PTPN2RPS6KA5MAPKAPK2PNLIP | |
| SCHEMBL25433754 | 0.79 | PTPN2 (0.64) | PTPN1PTPN2RPS6KA5MAPKAPK2PNLIP | |
| SCHEMBL25436073 | 0.79 | PTPN2 (0.64) | PTPN1PTPN2RPS6KA5MAPKAPK2PNLIP | |
| SCHEMBL25435120 | 0.79 | PTPN2 (0.64) | PTPN1PTPN2RPS6KA5MAPKAPK2PNLIP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4103640-B1 | NEW METHOD OF SYNTHESIS OF CHITOSAN DERIVATIVES AND USES THEREOF | NOVOCHIZOL SA (CH) | 2025-02-26 | — | — | EP | disclosed |
| US-20230096466-A1 | NEW METHOD OF SYNTHESIS OF CHITOSAN DERIVATIVES AND USES THEREOF | NOVOCHIZOL SA (CH) | 2023-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230096466-A1 | NEW METHOD OF SYNTHESIS OF CHITOSAN DERIVATIVES AND USES THEREOF | CHIA, CHIT1, CHI3L2 | PTPN1 3999/4885PTPN2 3658/4885RPS6KA5 3093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.